These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2889942

  • 1. Hepatotoxicity due to bindazac.
    Ballesteros JA, Badosa AM, Usandizaga I, Amengual M.
    Lancet; 1987 Oct 31; 2(8566):1030-1. PubMed ID: 2889942
    [No Abstract] [Full Text] [Related]

  • 2. [Bendazac hepatotoxicity: analysis of 16 cases].
    Prieto de Paula JM, Rodríguez Rodríguez E, Villamandos Nicás V, Sanz de la Fuente H, Prada Mínguez A, del Portillo Rubí A.
    Rev Clin Esp; 1995 Jun 31; 195(6):387-9. PubMed ID: 7644786
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Chronic active hepatitis due to bendazac].
    Rodríguez Rodríguez E, Prieto de Paula JM, Cancelo Suárez P, Echevarría Iturbe C.
    Rev Clin Esp; 1994 Aug 31; 194(8):657-8. PubMed ID: 7938854
    [No Abstract] [Full Text] [Related]

  • 5. Hepatotoxicity due to lysine salt of bendazac.
    Alcalde M, Garcia-Diaz M, Najarro F, Donoso MS, Cebria L, Pascasio JM.
    Scand J Gastroenterol; 1996 Feb 31; 31(2):206-8. PubMed ID: 8658045
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drug Points: Cholestatic hepatitis in association with celecoxib.
    O'Beirne JP, Cairns SR.
    BMJ; 2001 Jul 07; 323(7303):23. PubMed ID: 11440939
    [No Abstract] [Full Text] [Related]

  • 11. [Nimesulide-induced hepatotoxicity].
    Gallego Rojo FJ, Fernández Pérez F, Fernández Pérez R, Porcel A, Blas JM, Díez F.
    Rev Esp Enferm Dig; 2002 Jan 07; 94(1):41-2. PubMed ID: 12073669
    [No Abstract] [Full Text] [Related]

  • 12. Nonsteroidal anti-inflammatory drug-induced hepatoxicity.
    Unzueta A, Vargas HE.
    Clin Liver Dis; 2013 Nov 07; 17(4):643-56, ix. PubMed ID: 24099022
    [Abstract] [Full Text] [Related]

  • 13. [Hepatotoxicity of nimesulide].
    Castañeda Hernández G, Barragán Padilla SB.
    Gac Med Mex; 2004 Nov 07; 140(6):679. PubMed ID: 15633581
    [No Abstract] [Full Text] [Related]

  • 14. Nimesulide-induced acute hepatotoxicity.
    Papaioannides D, Korantzopoulos P, Athanassiou E, Sinapidis D.
    Indian J Gastroenterol; 2003 Nov 07; 22(6):239. PubMed ID: 15030049
    [No Abstract] [Full Text] [Related]

  • 15. Acute hepatocellular and cholestatic injury in a patient taking celecoxib.
    Nachimuthu S, Volfinzon L, Gopal L.
    Postgrad Med J; 2001 Aug 07; 77(910):548-50. PubMed ID: 11470953
    [Abstract] [Full Text] [Related]

  • 16. Nimesulide-induced hepatotoxicity and fatal hepatic failure.
    Bissoli F.
    Singapore Med J; 2008 May 07; 49(5):436-7; author reply 438. PubMed ID: 18465058
    [No Abstract] [Full Text] [Related]

  • 17. Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents.
    Zimmerman HJ.
    Semin Liver Dis; 1990 Nov 07; 10(4):322-38. PubMed ID: 2281340
    [No Abstract] [Full Text] [Related]

  • 18. [Hypersensitivity to celecoxib].
    Fradet G, Robin-Le Nechet A, Huguenin H, Chiffoleau A.
    Ann Med Interne (Paris); 2003 May 07; 154(3):181-2. PubMed ID: 12910047
    [Abstract] [Full Text] [Related]

  • 19. The effects of Bendaline on cataracts.
    Rhee SW, Youn DH, Lee J, Choi O, Jung HR.
    Korean J Ophthalmol; 1987 Jun 07; 1(1):31-4. PubMed ID: 3333943
    [No Abstract] [Full Text] [Related]

  • 20. [Fulminant liver failure due to bendazac].
    Hermo JA, Pineda JR, Alfonsín N, Rodríguez A.
    Med Clin (Barc); 1995 Mar 18; 104(10):396. PubMed ID: 7707735
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.